CH625052A5 - - Google Patents

Download PDF

Info

Publication number
CH625052A5
CH625052A5 CH1514576A CH1514576A CH625052A5 CH 625052 A5 CH625052 A5 CH 625052A5 CH 1514576 A CH1514576 A CH 1514576A CH 1514576 A CH1514576 A CH 1514576A CH 625052 A5 CH625052 A5 CH 625052A5
Authority
CH
Switzerland
Prior art keywords
activity
factor
xal
sulfate
polysaccharide
Prior art date
Application number
CH1514576A
Other languages
German (de)
English (en)
Inventor
Ee Thye Yin
Oddvar Tangen
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of CH625052A5 publication Critical patent/CH625052A5/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96444—Factor X (3.4.21.6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, e.g. Konjac gum, Locust bean gum, Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CH1514576A 1975-12-01 1976-12-01 CH625052A5 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7513495A SE419871B (sv) 1975-12-01 1975-12-01 Sett att bestemma aktiviteten hos faktor xa-inhibitor i blod

Publications (1)

Publication Number Publication Date
CH625052A5 true CH625052A5 (ja) 1981-08-31

Family

ID=20326201

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1514576A CH625052A5 (ja) 1975-12-01 1976-12-01

Country Status (15)

Country Link
US (1) US4139415A (ja)
JP (1) JPS5915640B2 (ja)
AT (1) AT348687B (ja)
AU (1) AU508343B2 (ja)
BE (1) BE848932A (ja)
CA (1) CA1060324A (ja)
CH (1) CH625052A5 (ja)
DE (1) DE2654189C3 (ja)
DK (1) DK537676A (ja)
FI (1) FI63494C (ja)
FR (1) FR2334109A1 (ja)
GB (1) GB1562808A (ja)
NL (1) NL7613376A (ja)
NO (1) NO148960C (ja)
SE (1) SE419871B (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2757992A1 (de) * 1977-12-24 1979-06-28 Boehringer Mannheim Gmbh Verfahren zur prothrombin-bestimmung
US4302538A (en) * 1978-03-27 1981-11-24 Ortho Diagnostics Inc. Buffer system in an anti-thrombin III test
SE422081B (sv) * 1979-08-22 1982-02-15 Ird Biomaterial Ab Sett att pavisa proteolytiska enzymer
CA1161432A (en) * 1980-02-12 1984-01-31 Lars G. Svendsen Tripeptide derivatives and their application in assaying enzymes
WO1982001377A1 (en) * 1980-10-09 1982-04-29 Lill Helmut Method for determining a bm-antithrombin
US4753875A (en) * 1981-11-02 1988-06-28 Ryan James W Method for assaying proteases with tagged proteinaceous inhibitors
US5221614A (en) * 1988-03-03 1993-06-22 Nippon Shoji Kabushiki Kaisha Method and reagent for determining the biological activity of antithrombin III by measuring coagulation time
GB9602166D0 (en) * 1996-02-02 1996-04-03 Zeneca Ltd Aminoheterocyclic derivatives
DE19634312A1 (de) * 1996-08-24 1998-02-26 Behringwerke Ag Verfahren zur Herstellung von Faktor V-Mangelplasma und ein so erhaltenes Mangelplasma
US6432658B1 (en) 2000-09-13 2002-08-13 Affinity Biologicals, Inc. Method for measuring antithrombin activity
EP2818871A1 (en) * 2013-06-28 2014-12-31 Roche Diagniostics GmbH Means and methods for universal calibration of anti-Factor Xa tests

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE380257B (sv) * 1972-05-02 1975-11-03 Bofors Ab Nya diagnostiskt verksamma substrat med hog specificitet till trombin och andra proteolytiska enzymer av typen peptidyl-peptid-hydrolaser
US3985618A (en) * 1975-05-02 1976-10-12 Irving Innerfield Method for detection of thrombosis and prethrombosis

Also Published As

Publication number Publication date
FI63494C (fi) 1983-06-10
FI763446A (ja) 1977-06-02
US4139415A (en) 1979-02-13
DE2654189A1 (de) 1977-06-08
FI63494B (fi) 1983-02-28
BE848932A (fr) 1977-05-31
AU508343B2 (en) 1980-03-20
NO148960C (no) 1984-01-18
DE2654189C3 (de) 1985-10-03
ATA891076A (de) 1978-07-15
FR2334109A1 (fr) 1977-07-01
FR2334109B1 (ja) 1982-03-12
AU2006176A (en) 1978-06-08
SE7513495L (sv) 1977-06-02
AT348687B (de) 1979-02-26
DK537676A (da) 1977-06-02
JPS5915640B2 (ja) 1984-04-10
GB1562808A (en) 1980-03-19
DE2654189B2 (de) 1979-03-08
JPS5297792A (en) 1977-08-16
NO764081L (ja) 1977-06-02
NL7613376A (nl) 1977-06-03
CA1060324A (en) 1979-08-14
NO148960B (no) 1983-10-10
SE419871B (sv) 1981-08-31

Similar Documents

Publication Publication Date Title
EP0915340B1 (de) Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe und Verfahren zur Bestimmung der Glykosilierung von Thrombomodulin
EP0018353B1 (de) Verfahren zur Herstellung von nebenwirkungsfreien Plasmafraktionen
DE3127318A1 (de) Blutgerinnungsfoerdernde praeparation auf basis von humanproteinen sowie verfahren zu ihrer herstellung
DE102005028018A1 (de) Verfahren zur Standardisierung von Gerinnungstesten
DE1189763B (de) Reagens zur Kontrolle der Gerinnungsfaehigkeit des Blutes waehrend einer Antikoagulantien-Therapie und Verfahren zur Herstellung des Reagens
EP0049877B1 (de) Verfahren und Reagenz zur Bestimmung von Antithrombin-BM
CH625052A5 (ja)
EP2484776A1 (de) Heparin-insensitives Verfahren zur Bestimmung von direkten Gerinnungsfaktorinhibitoren
EP1752772B1 (de) Faktor Xa basiertes Heparin-Testverfahren unter Verwendung einer Heparin-modifizierenden Komponente
EP0236985A2 (de) Verfahren zur photometrischen Bestimmung der Protein C- und/oder Protein S-Aktivität
DE3034142C2 (ja)
EP0711838A1 (de) Verfahren zum spezifischen Nachweis eines aktivierten Gerinnungsfaktors V mit einer erhöhten Stabilität gegenüber aktiviertem Protein C
DE112006003476T5 (de) Verfahren und Systeme zum Nachweisen und Quantifizieren indirekter Thrombininhibitoren
EP0062310B1 (de) Reagens zur optischen Bestimmung des Blutgerinnungsverhaltens
DE2757992A1 (de) Verfahren zur prothrombin-bestimmung
DE60032001T2 (de) Verfahren zur stabilisierung von thrombin
DE4429660B4 (de) Zusatzmittel für diagnostische Tests zur Bestimmung der Gerinnungsfähigkeit des Blutes, Verfahren zur Reduzierung der Beeinflussung von diagnostischen Tests durch Heparin und Verwendung von Metallsalzen zu diesen Zwecken
DE2641840A1 (de) Thrombose-test
CH626919A5 (ja)
EP0570356B1 (de) Reagens zur Bestimmung der aktivierten partiellen Thromboplastinzeit (aPTT)
EP0408075B1 (de) Verfahren und Reagenz zur Bestimmung von Antithrombin III
EP0182929A1 (de) Koaktivator zur Aktivierung von Protein C
AT397391B (de) Verwendung von prothrombinfragmenten
DE69916816T2 (de) Verbesserter blutgerinnungstest
DE3390431T1 (de) Test für autoimmune rheumatoide Arthritis

Legal Events

Date Code Title Description
PL Patent ceased